Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Cai, Xiaoling ^a   Han, Xueyao ^a   Zhang, Simin ^a   Luo, Yingying ^a   Chen, Yingli ^a   Ji, Linong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; THYROTROPIN; URIC ACID;

ADULT; ARTERIOSCLEROSIS; ARTICLE; BODY MASS; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THYROTROPIN BLOOD LEVEL; URINALYSIS; URINE ALBUMIN TO CREATININE RATIO; AGE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; COMPLICATION; DEMOGRAPHY; DIET RESTRICTION; HOSPITALIZATION; METABOLISM; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTPRANDIAL STATE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; C-PEPTIDE; CHINA; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FASTING; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTPRANDIAL PERIOD; PREVALENCE; THYROTROPIN;

EID: 84897483291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091174     Document Type: Article

References (33)

1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-31. (Pubitemid 28405191)
2. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301: 2129-40.
3. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med 362(12): 1090-101.
4. Porta M, Bandello F (2002) Diabetic retinopathy: a clinical update. Diabetologia 45: 1617-34. (Pubitemid 35478131)
5. Kostev K, Rathmann W (2013) Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis. Diabetologia 56(1): 109-11.
6. Cai XL, Wang F, Ji LN (2006) Risk factors of diabetic retinopathy in type 2 diabetic patients. Chin. Med. J. 119(10): 822-826. (Pubitemid 43796811)
7. Kim JH, Kwon HS, Park YM, Lee JH, Kim MS, et al. (2011) Prevalence and Associated Factors of Diabetic Retinopathy in Rural Korea: The Chungju Metabolic Disease Cohort Study. J Korean Med Sci 26: 1068-1073.
8. Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL, et al. (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344: e874.
9. Mosier MA (1984) Circulating C-peptide and diabetic retinopathy. Diabetes Res 1(3): 151-4. (Pubitemid 14065420)
10. Nakanishi K, Watanabe C (2008) Rate of beta-cell destruction in type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual beta-cell function for more than 10 years. J Clin Endocrinol Metab 93(12): 4759-66.
11. Klein R, Klein BE, Moss SE (1995) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 44(7): 796-801.
12. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, et al. (2003) Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110: 1677-82. (Pubitemid 37025422)
13. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, et al. (2005) Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 46: 2328-2333. (Pubitemid 43119476)
14. Wong TY, Klein R, IslamFM, Cotch MF, Folsom AR, et al. (2006) Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 141: 446-455.
15. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, et al. (2012) Global Prevalence and Major Risk Factors of Diabetic Retinopathy. Diabetes Care 35: 556-564.
16. Sivaprasad S, Gupta B, Gulliford MC, Dodhia H, Mohamed M, et al. (2012) Ethnic Variations in the Prevalence of Diabetic Retinopathy in People with Diabetes Attending Screening in the United Kingdom (DRIVE UK). PLoS ONE 7(3): e32182.
17. Liu L, Wu X, Liu L, Geng J, Yuan Z, et al. (2012) Prevalence of Diabetic Retinopathy in Mainland China: A Meta-Analysis. PLoS ONE 7(9): e45264.
18. Chuang LM, Soegondo S, Soewondo P, Young-Seol K, Mohamed M, et al. (2006) Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Res Clin Pract 71(2): 146-55. (Pubitemid 43112106)
19. Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, et al. (1997) Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 20(5): 844-7. (Pubitemid 27202539)
20. Song SH, Gray TA (2011) Early-onset type 2 diabetes: high risk for premature diabetic retinopathy. Diabetes Res Clin Pract 94(2): 207-11.
21. Steffes MW, Sibley S, Jackson M, Thomas W (2003) b-Cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial. Diabetes Care 26 832-836. (Pubitemid 36929351)
22. Kim BY, Jung CH, Mok JO, Kang SK, Kim CH (2012) Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabeticpatients. Acta Diabetol 49(1): 9-15.
23. Zheng W (2011) Factor analysis of diabetic retinopathy in Chinese patients. Dia Res &Clin Prac 92: 244-252.
24. Yoon HJ, Cho YZ, Kim J, Kim BJ, Park KY, et al. (2012) Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients. Diabetes Metab J 36: 379-387.
25. Fukui T, Oono K, Hara N, Yamamoto T, Nagashima M, et al. (2013) Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: A long-term follow-up study. Endocrine Journal 60 (6), 715-724.
26. Bo S, Gentile L, Castiglione A, Prandi V, Canil S, et al. (2012) C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol 167(2): 173-80.
27. Klein R, Klein BE, Moss SE (1995) TheWisconsin Epidemiologic Study of diabetic retinopathy, XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 44: 796-801.
28. Gottsater A, Ahmed M, Fernlund P, Sundkvist G (1999) Autonomic neuropathy in type-2 diabetic patients is associated with hyperinsulinemia and hypertriglyceridemia. Diabetic Medicine 16: 49-54. (Pubitemid 29147223)
29. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, et al. (2003) The Prevalence of and Factors Associated With Diabetic Retinopathy in the Australian Population. Diabetes Care 26(6): 1731-7. (Pubitemid 36929112)
30. Yang JK, Liu W, Shi J, Li YB (2010) An Association Between Subclinical Hypothyroidism and Sight-Threatening Diabetic Retinopathy in Type 2 Diabetic Patients. Diabetes Care 33: 1018-1020.
31. Kim BY, Kim CH, Jung CH, Mok JO, Suh KI, et al. (2011) Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes. Endocrine Journal 58 (12), 1065-1070.
32. Ramis JN, Artigas CF, Santiago MA, Mañes FJ, Canonge RS, et al. (2012) Is there a relationship between TSH levels and diabetic retinopathy in the Caucasian population? Diabetes Res Clin Pract 97(3):e45-7.
33. Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, et al. (2007) Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet Med 24: 1336-1344.